| You have been chosen to receive this valuable information. |
 |
|
|
|
|
Why invest in cryo-EM? Design more effective drugs faster Are you interested in quickly developing more effective drugs? Increasingly, pharmaceutical companies are investing in cryo-electron microscopy (cryo-EM) to achieve structural insights that were unattainable through other methods, thereby accelerating their drug discovery process.
|
|
|
More than 30 cryo-EM systems utilized by Pharma for drug discovery*
|
|
1 out of 3 companies invest in additional microscope(s) within 2 years, based on proven outcomes and return on their investment
|
|
Your return on investment: Your investment may result in... |
|
|
|
|
Within 3‐4 years, your investment can pay for itself**
|
|
Your investment may result in a Net Present Value in the range of $10‐15M and Internal Rate of Return of more than 25%**
|
|
|
|
|
|
Not sure how to get started?
|
If you want to take advantage of cryo-EM's exciting applications in biology but find the cost of in-house adoption too prohibitive, there are options for you. We partner with a number of cryo-EM service providers around the world.
Try testing your sample with Cryo-EM as a service first ›
|
 |
|
|
|
|
Would you like to have your business case calculated? Contact us › |
|
|
|
|
* Status at the end of 2019
** Calculations are illustrative for an approximate $9M investment on a 10 year horizon. All financial indicators are estimates only.
Thermo Fisher Scientific makes no guarantee or representation with respect to its applicability to the customer’s particular business situation.
|
|
|
|
|
|
| Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, an MJH Life Science™ brand. You are on the mailing list as %%emailaddress%%. |
